HAC(SH:600202) Zhong Guo Zheng Quan Bao - Zhong Zheng Wang·2025-12-30 08:03Group 1 - The company received a government subsidy of 1,000,000.00 yuan, which will positively impact its profit for the fiscal year 2025 [2][3] - The subsidy is classified as a government grant related to income and will be recognized in the current profit and loss statement [2] Group 2 - The company has completed the transfer of 40% equity in its subsidiary, Harbin Fushanchuan Biotechnology Development Co., Ltd., to Harbin Industrial Investment Group Co., Ltd. for 3.8126 million yuan [5][7] - This transaction is classified as a related party transaction but does not constitute a major asset restructuring, as the buyer holds 34.03% of the company's shares [5][9] - The subsidiary reported a net loss of 16.0963 million yuan for 2024, which is 218.83% of the company's previous year's net profit [9] Group 3 - The company will no longer hold equity in Fushanchuan and will not consolidate it into its financial statements following the transaction [5][17] - The company has confirmed that there are no outstanding debts or financial obligations between it and Fushanchuan as of the announcement date [17] - The transaction is expected to optimize resource allocation and align with the company's strategic focus [17]